{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T11:28:59Z","timestamp":1760441339139},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,5,26]],"date-time":"2016-05-26T00:00:00Z","timestamp":1464220800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s40618-016-0489-6","type":"journal-article","created":{"date-parts":[[2016,5,26]],"date-time":"2016-05-26T16:51:53Z","timestamp":1464281513000},"page":"1383-1390","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Supra-physiological rhGH administration induces gender-related differences in the hypothalamus\u2013pituitary\u2013thyroid (HPT) axis in healthy individuals"],"prefix":"10.1007","volume":"39","author":[{"given":"P.","family":"Sgr\u00f2","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Sansone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Parisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Sartorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Sansone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Romanelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Lenzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Di Luigi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,26]]},"reference":[{"key":"489_CR1","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1373\/clinchem.2005.047845","volume":"51","author":"CM McHugh","year":"2005","unstructured":"McHugh CM, Park RT, S\u00f6nksen PH, Holt RI (2005) Challenges in detecting the abuse of growth hormone in sport. Clin Chem 51:1587\u20131593","journal-title":"Clin Chem"},{"key":"489_CR2","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1055\/s-2007-964991","volume":"28","author":"L Luigi Di","year":"2007","unstructured":"Di Luigi L, Rossi C, Sgr\u00f2 P, Fierro V, Romanelli F, Baldari C, Guidetti L (2007) Do non-steroidal anti-inflammatory drugs influence the steroid hormone milieu in male athletes? Int J Sports Med 28:809\u2013814","journal-title":"Int J Sports Med"},{"key":"489_CR3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.csm.2007.09.003","volume":"27","author":"L Luigi Di","year":"2008","unstructured":"Di Luigi L (2008) Supplements and the endocrine system in athletes. Clin Sports Med 27:131\u2013151","journal-title":"Clin Sports Med"},{"key":"489_CR4","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1055\/s-2007-965131","volume":"29","author":"L Luigi Di","year":"2008","unstructured":"Di Luigi L, Baldari C, Pigozzi F, Emerenziani GP, Gallotta MC, Iellamo F, Ciminelli E, Sgr\u00f2 P, Romanelli F, Lenzi A, Guidetti L (2008) The long-acting phosphodiesterase inhibitor tadalafil does not influence athletes\u2019 VO2max, aerobic, and anaerobic thresholds in normoxia. Int J Sports Med 29:110\u2013115","journal-title":"Int J Sports Med"},{"key":"489_CR5","doi-asserted-by":"crossref","first-page":"E972","DOI":"10.1152\/ajpendo.00573.2011","volume":"302","author":"L Luigi Di","year":"2012","unstructured":"Di Luigi L, Sgr\u00f2 P, Baldari C, Gallotta MC, Emerenziani GP, Crescioli C, Bianchini S, Romanelli F, Lenzi A, Guidetti L (2012) The phosphodiesterases type 5 inhibitor tadalafil reduces the activation of the hypothalamus\u2013pituitary\u2013adrenal axis in men during cycle ergometric exercise. Am J Physiol Endocrinol Metab 302:E972\u2013E978","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"489_CR6","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/bjp.2008.99","volume":"154","author":"RI Holt","year":"2008","unstructured":"Holt RI, S\u00f6nksen PH (2008) Growth hormone, IGF-I and insulin and their abuse in sport. Br J Pharmacol 154:542\u2013556","journal-title":"Br J Pharmacol"},{"key":"489_CR7","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2265.2004.02129.x","volume":"61","author":"A Sartorio","year":"2004","unstructured":"Sartorio A, Agosti F, Marazzi N, Maffiuletti NA, Cella SG, Rigamonti AE, Guidetti L, Di Luigi L, Muller EE (2004) Combined evaluation of resting IGF-I, N-terminal propeptide of type III procollagen (PIIINP) and C-terminal cross-linked telopeptide of type I collagen (ICTP) levels might be useful for detecting inappropriate GH administration in athletes: a preliminary report. Clin Endocrinol (Oxf) 61:487\u2013493","journal-title":"Clin Endocrinol (Oxf)"},{"key":"489_CR8","doi-asserted-by":"crossref","first-page":"i35","DOI":"10.1136\/bjsm.2006.027573","volume":"40","author":"M Saugy","year":"2006","unstructured":"Saugy M, Robinson N, Saudan C, Baume N, Avois L, Mangin P (2006) Human growth hormone doping in sport. Br J Sports Med 40:i35\u2013i39","journal-title":"Br J Sports Med"},{"key":"489_CR9","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1210\/jc.2011-0179","volume":"96","author":"ME Molitch","year":"2011","unstructured":"Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Vance ML, Endocrine Society (2011) Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1587\u20131609","journal-title":"J Clin Endocrinol Metab"},{"key":"489_CR10","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1210\/jcem-45-2-324","volume":"45","author":"T Sato","year":"1977","unstructured":"Sato T, Suzukui Y, Taketani T, Ishiguro K, Masuyama T (1977) Enhanced peripheral conversion of thyroxine to triiodothyronine during hGH therapy in GH deficient children. J Clin Endocrinol Metab 45:324\u2013329","journal-title":"J Clin Endocrinol Metab"},{"key":"489_CR11","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1530\/eje.0.1340563","volume":"134","author":"MA Hussain","year":"1996","unstructured":"Hussain MA, Schmitz O, Jorgensen JO, Christiansen JS, Weeke J, Schmid C, Froesch ER (1996) Insulin-like growth factor I alters peripheral thyroid hormone metabolism in humans: comparison with growth hormone. Eur J Endocrinol 134:563\u2013567","journal-title":"Eur J Endocrinol"},{"key":"489_CR12","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1210\/jcem.87.5.8479","volume":"87","author":"S Porretti","year":"2002","unstructured":"Porretti S, Giavoli C, Ronchi C, Lombardi G, Zaccaria M, Valle D, Arosio M, Beck-Peccoz P (2002) Recombinant human GH replacement therapy and thyroid function in a large group of adult GH-deficient patients: when does L-T(4) therapy become mandatory? J Clin Endocrinol Metab 87:2042\u20132045","journal-title":"J Clin Endocrinol Metab"},{"key":"489_CR13","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1210\/jcem-28-5-603","volume":"28","author":"L Oliner","year":"1968","unstructured":"Oliner L, Ballantine JJ (1968) Effect of human growth hormone on thyroidal secretion, radiothyroxine turnover and transport in man. J Clin Endocrinol Metab 28:603\u2013607","journal-title":"J Clin Endocrinol Metab"},{"key":"489_CR14","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1210\/jcem-67-5-1111","volume":"67","author":"C Grunfeld","year":"1988","unstructured":"Grunfeld C, Sherman BM, Cavalieri RR (1988) The acute effects of human growth hormone administration on thyroid function in normal men. J Clin Endocrinol Metab 67:1111\u20131114","journal-title":"J Clin Endocrinol Metab"},{"key":"489_CR15","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/0026-0495(92)90312-X","volume":"41","author":"J M\u00f8ller","year":"1992","unstructured":"M\u00f8ller J, J\u00f8rgensen JO, M\u00f8ller N, Christiansen JS, Weeke J (1992) Effects of growth hormone administration on fuel oxidation and thyroid function in normal man. Metabolism 41:728\u2013731","journal-title":"Metabolism"},{"key":"489_CR16","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2265.2005.02216.x","volume":"62","author":"MG Giannoulis","year":"2005","unstructured":"Giannoulis MG, Boroujerdi MA, Powrie J, Dall R, Napoli R, Ehrnborg C, Pentecost C, Cittadini A, J\u00f8rgensen JO, Sonksen PH, GH-2000 Study Group (2005) Gender differences in growth hormone response to exercise before and after rhGH administration and the effect of rhGH on the hormone profile of fit normal adults. Clin Endocrinol (Oxf) 62:315\u2013322","journal-title":"Clin Endocrinol (Oxf)"},{"key":"489_CR17","first-page":"265","volume":"35","author":"NT Leite","year":"2012","unstructured":"Leite NT, Salvatori R, Alc\u00e2ntara MR, Alc\u00e2ntara PR, Oliveira CR, Oliveira JL, Anjos-Andrade FD, Farias MI, Britto CT, N\u00f3brega LM, Nascimento AC Jr, Alves \u00c9O, Pereira RM, Campos VC, Menezes M, Martinelli CE Jr, Aguiar-Oliveira MH (2012) Effects of depot growth hormone replacement on thyroid function and volume in adults with congenital isolated growth hormone deficiency. J Endocrinol Invest 35:265\u2013268","journal-title":"J Endocrinol Invest"},{"key":"489_CR18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2265.2010.03815.x","volume":"74","author":"LA Behan","year":"2011","unstructured":"Behan LA, Monson JP, Agha A (2011) The interaction between growth hormone and the thyroid axis in hypopituitary patients. Clin Endocrinol (Oxf) 74:281\u2013288","journal-title":"Clin Endocrinol (Oxf)"},{"key":"489_CR19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1365-2265.2001.01344.x","volume":"55","author":"KH Lange","year":"2001","unstructured":"Lange KH, Isaksson F, Rasmussen MH, Juul A, B\u00fclow J, Kjaer M (2001) GH administration and discontinuation in healthy elderly men: effects on body composition, GH-related serum markers, resting heart rate and resting oxygen uptake. Clin Endocrinol (Oxf). 55:77\u201386","journal-title":"Clin Endocrinol (Oxf)."},{"key":"489_CR20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1365-2265.2000.01071.x","volume":"53","author":"ES Portes","year":"2000","unstructured":"Portes ES, Oliveira JH, MacCagnan P, Abucham J (2000) Changes in serum thyroid hormones levels and their mechanisms during long-term growth hormone (GH) replacement therapy in GH deficient children. Clin Endocrinol (Oxf). 53:183\u2013189","journal-title":"Clin Endocrinol (Oxf)."},{"key":"489_CR21","doi-asserted-by":"crossref","first-page":"972617","DOI":"10.1155\/2012\/972617","volume":"2012","author":"N Glynn","year":"2012","unstructured":"Glynn N, Agha A (2012) Diagnosing growth hormone deficiency in adults. Int J Endocrinol. 2012:972617","journal-title":"Int J Endocrinol."},{"key":"489_CR22","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1172\/JCI117299","volume":"94","author":"M Bermann","year":"1994","unstructured":"Bermann M, Jaffe CA, Tsai W, DeMott-Friberg R, Barkan AL (1994) Negative feedback regulation of pulsatile growth hormone secretion by insulin-like growth factor I Involvement of hypothalamic somatostatin. J Clin Invest 94:138\u2013145","journal-title":"J Clin Invest"},{"key":"489_CR23","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000122921","volume":"29","author":"A Kanatsuka","year":"1979","unstructured":"Kanatsuka A, Makino H, Matsushima Y, Osegawa M, Yamamoto M, Kumagai A (1979) Effect of hypophysectomy and growth hormone administration on somatostatin content in the rat hypothalamus. Neuroendocrinology 29:186\u2013190","journal-title":"Neuroendocrinology"},{"key":"489_CR24","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/BF03346893","volume":"20","author":"MC Ghigo","year":"1997","unstructured":"Ghigo MC, Torsello A, Grilli R, Luoni M, Guidi M, Cella SG, Locatelli V, M\u00fcller EE (1997) Effects of GH and IGF-I administration on GHRH and somatostatin mRNA levels: I. A study on ad libitum fed and starved adult male rats. J Endocrinol Invest 20:144\u2013150","journal-title":"J Endocrinol Invest"},{"key":"489_CR25","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000351007","volume":"2","author":"P Beck-Peccoz","year":"2013","unstructured":"Beck-Peccoz P, Lania A, Beckers A, Chatterjee K, Wemeau JL (2013) 2013 European thyroid association guidelines for the diagnosis and treatment of thyrotropin-secreting pituitary tumors. Eur Thyroid J. 2:76\u201382","journal-title":"Eur Thyroid J."},{"key":"489_CR26","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/BF03401537","volume":"11","author":"AC Hackney","year":"2012","unstructured":"Hackney AC, Kallman A, Hosick KP, Rubin DA, Battaglini CL (2012) Thyroid hormonal responses to intensive interval versus steady-state endurance exercise sessions. Hormones 11:54\u201360","journal-title":"Hormones"},{"key":"489_CR27","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2265.1992.tb02332.x","volume":"37","author":"JK Rone","year":"1992","unstructured":"Rone JK, Dons RF, Reed HL (1992) The effect of endurance training on serum triiodothyronine kinetics in man: physical conditioning marked by enhanced thyroid hormone metabolism. Clin Endocrinol 37:325\u2013330","journal-title":"Clin Endocrinol"},{"key":"489_CR28","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-2265.2006.02688.x","volume":"66","author":"A Agha","year":"2007","unstructured":"Agha A, Walker D, Perry L, Drake WM, Chew SL, Jenkins PJ, Grossman AB, Monson JP (2007) Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients. Clin Endocrinol (Oxf) 66:72\u201377","journal-title":"Clin Endocrinol (Oxf)"},{"key":"489_CR29","first-page":"830","volume":"26","author":"F Ciloglu","year":"2005","unstructured":"Ciloglu F, Peker I, Pehlivan A, Karacabey K, Ilhan N, Saygin O, Ozmerdivenli R (2005) Exercise intensity and its effects on thyroid hormones. Neuro Endocrinol Lett 26:830\u2013834","journal-title":"Neuro Endocrinol Lett"},{"key":"489_CR30","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1089\/10507250050137716","volume":"10","author":"FH Curty","year":"2000","unstructured":"Curty FH, Lisb\u00f4a PC, Ortiga-Carvalho TM, Pazos-Moura CC (2000) The somatostatin analogue octreotide modulates Iodothyronine deiodinase activity and pituitary neuromedin B. Thyroid 10:647\u2013652","journal-title":"Thyroid"},{"key":"489_CR31","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/s00018-007-7396-0","volume":"65","author":"B Gereben","year":"2008","unstructured":"Gereben B, Ze\u00f6ld A, Dentice M, Salvatore D, Bianco AC (2008) Activation and inactivation of thyroid hormone by deiodinases: local action with general consequences. Cell Mol Life Sci 65:570\u2013590","journal-title":"Cell Mol Life Sci"},{"key":"489_CR32","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2265.1994.tb01826.x","volume":"41","author":"JO J\u00f8rgensen","year":"1994","unstructured":"J\u00f8rgensen JO, M\u00f8ller J, Laursen T, Orskov H, Christiansen JS, Weeke J (1994) Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose-dependent manner and suppresses circadian thyrotropin levels: studies in GH-deficient adults. Clin Endocrinol (Oxf) 41:609\u2013614","journal-title":"Clin Endocrinol (Oxf)"},{"key":"489_CR33","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.regpep.2010.06.010","volume":"165","author":"P Sgr\u00f2","year":"2010","unstructured":"Sgr\u00f2 P, Guidetti L, Crescioli C, Baldari C, Romanelli F, Bianchini S, D\u2019Armiento M, Lenzi A, Di Luigi L (2010) Effect of supra-physiological dose administration of rhGH on pituitary\u2013thyroid axis in healthy male athletes. Regul Pept 165:163\u2013167","journal-title":"Regul Pept"},{"key":"489_CR34","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/iep.12024","volume":"94","author":"H Atkinson","year":"2013","unstructured":"Atkinson H, England JA, Rafferty A, Jesudason V, Bedford K, Karsai L, Atkin SL (2013) Somatostatin receptor expression in thyroid disease. Int J Exp Pathol 94:226\u2013229","journal-title":"Int J Exp Pathol"},{"key":"489_CR35","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1210\/endo.139.5.5990","volume":"139","author":"D Djordjijevic","year":"1998","unstructured":"Djordjijevic D, Zhang J, Priam M, Viollet C, Gourdji D, Kordon C, Epelbaum J (1998) Effect of 17beta-estradiol on somatostatin receptor expression and inhibitory effects on growth hormone and prolactin release in rat pituitary cell cultures. Endocrinology 139:2272\u20132277","journal-title":"Endocrinology"},{"key":"489_CR36","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1210\/endo.139.4.5952","volume":"139","author":"N Kimura","year":"1998","unstructured":"Kimura N, Tomizawa S, Arai KN, Kimura N (1998) Chronic treatment with estrogen up-regulates expression of sst2 messenger ribonucleic acid (mRNA) but down-regulates expression of sst5 mRNA in rat pituitaries. Endocrinology 139:1573\u20131580","journal-title":"Endocrinology"},{"key":"489_CR37","first-page":"550","volume":"82","author":"P Burman","year":"1997","unstructured":"Burman P, Johansson AG, Siegbahn A, Vessby B, Karlsson FA (1997) Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women. J Clin Endocrinol Metab 82:550\u2013555","journal-title":"J Clin Endocrinol Metab"},{"key":"489_CR38","doi-asserted-by":"crossref","first-page":"E1006","DOI":"10.1152\/ajpendo.00166.2005","volume":"290","author":"T M\u00fcnzer","year":"2006","unstructured":"M\u00fcnzer T, Rosen CJ, Harman SM, Pabst KM, St. Clair C, Sorkin JD, Blackman MR (2006) Effects of GH and\/or sex steroids on circulating IGF-I and IGFBPs in healthy, aged women and men. Am J Physiol Endocrinol Metab 290:E1006\u2013E1013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"489_CR39","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1530\/EJE-13-0733","volume":"170","author":"C Norman","year":"2013","unstructured":"Norman C, Rollene NL, Erickson D, Miles JM, Bowers CY, Veldhuis JD (2013) Estradiol regulates GH-releasing peptide\u2019s interactions with GH-releasing hormone and somatostatin in postmenopausal women. Eur J Endocrinol 170:121\u2013129","journal-title":"Eur J Endocrinol"},{"key":"489_CR40","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1073\/pnas.0337600100","volume":"100","author":"KC Leung","year":"2003","unstructured":"Leung KC, Doyle N, Ballesteros M, Sjogren K, Watts CK, Low TH, Leong GM, Ross RJ, Ho KK (2003) Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2. Proc Natl Acad Sci USA 100:1016\u20131021","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-016-0489-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-016-0489-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-016-0489-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-016-0489-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T04:51:22Z","timestamp":1718599882000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-016-0489-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,26]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["489"],"URL":"https:\/\/doi.org\/10.1007\/s40618-016-0489-6","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,26]]}}}